Regal Rexnord heads into the post-earnings tape with a beat on both lines — and options traders had already called the shift.
The most striking signal this week wasn't in the income statement. It was in the put/call ratio. Tuesday's PCR collapsed to 0.67, a full 3.5 standard deviations below the 20-day mean of 1.22. For context, the ratio had been running above 1.29 consistently for weeks — one of the more defensive readings of the past year. The abrupt pivot to calls just before Wednesday's print was a clear signal that some traders repositioned aggressively for an upside move. That move arrived. Q1 adjusted EPS came in at $2.17 against a $2.12 estimate. Revenue of $1.479B topped the $1.434B consensus. The stock rose 4.5% on Tuesday alone and 5.9% on the week, closing at $222.02.
Short interest gives a more complicated read. Bears have been slowly rebuilding — short interest as a percentage of the free float climbed to 3.8%, up roughly 34% over the past month in share terms. Most of that build accelerated in mid-April, with shares short jumping from around 1.74 million to over 2.5 million between April 9 and April 28. That's a meaningful accumulation ahead of earnings. The borrow market, however, tells a different story. Cost to borrow has eased to 0.44% from around 0.52% a week ago, and availability is loose — the lending pool is far from stressed. Short sellers were adding exposure into the print, but it wasn't a conviction crowding trade. It looked more like a hedge.
The Street had already been leaning positive. Following February's strong Q4 results, Goldman Sachs, JPMorgan, Barclays, Citi, and KeyBanc all raised price targets — some dramatically, with KeyBanc lifting to $255 from $200. The most recent action was Citi on April 13, raising its target to $240 while maintaining its Buy. With a consensus mean target near $242 and the stock now at $222, residual upside to target is modest but positive. Factor scores are mixed: EPS momentum ranks in the 64th percentile on a 30-day basis and the 60th on 90 days. EPS surprise, by contrast, scores only in the 19th percentile — though today's beat may revise that higher in coming datasets. The ORTEX short score at 35.6 is middling, consistent with a stock where neither side has a strong edge.
The guidance picture adds a wrinkle. The company affirmed its full-year adjusted EPS range of $10.20–$11.00, roughly bracketing the $10.79 consensus. GAAP EPS guidance, however, was trimmed — from $5.29–$6.09 to $5.18–$5.98, against an estimate of $6.55. That GAAP miss on guidance versus expectations reflects ongoing amortization and restructuring headwinds, a recurring theme for the company since the Rexnord acquisition. Net debt runs at approximately $3.73 billion against EBITDA of around $1.38 billion, so the balance sheet remains a watchpoint.
The two most recent earnings reactions in the data are instructive. The February 2026 print produced a 18.8% one-day gain and a 19.8% five-day gain. The prior print, in late 2025, delivered a more measured 8.3% and 10.1% over the same windows. Both were strong. The stock enters the post-print session having already moved 5.9% on the week, meaning some of the typical upside was front-run. Among closest peers, AME rose 2.4% on the week, ST gained 3.1%, and POWL surged 15.3%. HUBB went the other way, falling 6.8%. The divergence within the electrical/industrial space is wide, suggesting the sector is trading more on individual catalysts than macro themes right now.
The call for next week is straightforward: with earnings now released, the key issue is whether short sellers who built into the print cover quickly — or whether GAAP guidance noise invites further selling pressure against a stock that has already rallied hard from its April lows.
See the live data behind this article on ORTEX.
Open RRX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
